New gene therapy strategy could cure COPA Syndrome

Scientists compared five families and multiple generations to find a gene variant that prevents COPA Syndrome and opens the door to a new gene therapy for the condition.

Straumann Group 2024 third-quarter results webcast – Biotech Investments

Straumann Holding AG / Key word(s): 9 Month figures Invitation: Straumann Group 2024 third-quarter results webcast 16.10.2024 / 10:16 CET/CEST Date: Tuesday, October 29, 2024

October 17, 2024

In surprise move, FDA calls for advisory committee on Lilly’s Alzheimer’s drug

In a surprise move, the Food and Drug Administration has called for a meeting of outside advisers to discuss whether an Alzheimer’s drug from Eli

March 8, 2024

Structure’s oral GLP-1 a ‘work in progress’ following Phase IIa obesity and diabetes data

Phase IIa data for Structure Therapeutics’ oral GLP-1 drug candidate for type 2 diabetes and obesity bested analyst expectations on safety and tolerability, but lower-than-hoped-for

December 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.